[Stimulation therapies for Parkinson's disease: over the past two decades].
Levodopa has been the mainstay of treatment for Parkinson's disease since the 1960s, but the dyskinesias it induces are a major drawback. High-frequency deep brain stimulation offers a safe, reversible alternative. Targets include the thalamus, pallidum, subthalamic nucleus and, more recently, the pedunculopntine nucleus, which requires low-frequency excitation. The subthalamic nucleus is the preferred target in Parkinson's disease. Other treatments such as gene therapy are in the pipeline.